Search results for

News that South Korean scientists have successfully cloned a human embryo renews a debate over human cloning. On one side are scientists and patients who argue that cloning offers a way to produce healthy cells to treat diseases like diabetes and Parkinson's disease. On the other side are critics who insist that any form of cloning is morally repugnant. NPR's Joe Palca reports.

"I'm a Republican. Gasp!"

While Paris has been the favored destination for visitors seeking clues to the Holy Grail, Rome has drawn new attention. The book Angels and Demons has tourists seeking hidden meanings in the city's art and religious symbols.

Last week, we took a look at how Pete Wilson overcame the limitations of the council-manager system to become San Diego's first strong mayor. Now Pat Finn continues the story by showing us what he di

Goodbye 'Full Focus' -- We're Sorry to See You Go

The New York Fire Department releases dispatch tapes from the attacks of Sept. 11, 2001, along with transcripts of firefighters' oral histories recorded after the event. From member station WNYC, Beth Fertig reports.

Austrian novelist and playwright Elfriede Jelinek won the 2004 Nobel Prize in Literature on Thursday, becoming only the tenth woman to receive the honor. The feminist author is best known for her autobiographical novel, The Piano Teacher. NPR's Neda Ulaby reports.

Mao: The Unknown Story was written by Jung Chang, who described the suffering of her family during the cultural revolution in the bestseller Wild Swans and her husband, the historian Jon Halliday.

The Galileo spacecraft is sending back its final signals to Earth as its eight-year mission to Jupiter comes to an end. NASA mission managers are sending the spacecraft to its death by crashing it into the giant planet. NPR's Joe Palca reports.

Merck documents show that in 2000, the maker of Vioxx tried to censor critics of the drug's safety. That was the year that drug giant Merck learned that Vioxx might cause heart attacks and other problems. The documents show a concerted effort by the company to identify doctors who were raising questions about the drug's safety and to put pressure on them to stop making critical comments. A spokesman for Merck denies the allegations.